ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Measurement Instrument"

  • Abstract Number: 2307 • ACR Convergence 2025

    Peripheral Manifestations In Axial And Peripheral Spondyloarthritis: A Systematic Literature Review On Their Assessment In Clinical Trials

    AUGUSTA ORTOLAN1, Casper Webers2, Elena Nikiphorou3, Alexandre Sepriano4, Louise Falzon5, Clementina López Medina6, Dafne capelusnik7, Désirée Van Der Heijde8, Anna Molto9 and Sofia Ramiro10, 1Policlinico Universitario Agostino Gemelli IRCSS, Rome, Italy, 2Maastricht University Medical Centre, Maastricht, Netherlands, 3King's College London, London, United Kingdom, 4Department of Rheumatology, Leiden University Medical Centre, Portela Loures, Portugal, 5Sheffield Centre for Health and Related Research, University of Sheffield, Sheffield, United Kingdom, 6Department of Medicine, Hospital Universitario Reina Sofia, University of Cordoba, IMIBIC, Cordoba, Spain, 7Tel Aviv Sourasky Medical Center, Ramat Gan, Israel, 8Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 9Assistance Publique Hôpitauxde Paris, Paris, France, 10Leiden University Medical Center, Bunde, Netherlands

    Background/Purpose: Peripheral manifestations (peripheral arthritis, enthesitis, dactylitis) of axial spondyloarthritis (axSpA) and peripheral spondyloarthritis (pSpA) represent a significant burden for patients, but are understudied. Our…
  • Abstract Number: 0221 • ACR Convergence 2025

    A Multimodal Intervention Improves the Quantity and Quality of Disease Activity Measures Collection in a Multi-Centered National Rheumatoid Arthritis Network

    Grant Cannon1, Beth Wallace2, Deana Lazaro3, Pascale Schwab4, Paul Monach5, Ankoor Shah6, Gail Kerr7, Andreas Reimold8, Joshua Baker9, Gary Kunkel10, Katherine Wysham11, Liron Caplan12, John Richards13, Aleksander Lenert14, Andrew Jones15, Ted Mikuls16, Maria I. ("Maio") Danila17, Bryant England16, Brian Sauer18, Jorge Rojas19 and Isaac Smith20, 1University of Utah and Salt Lake City VA, Salt Lake City, UT, 2Michigan Medicine, VA Ann Arbor Healthcare System, Ann Arbor, MI, 3VA New York Harbor Healthcare system, Short Hills, NJ, 4VA Portland and Oregon Health & Science University, Portland, OR, 5VA Boston Healthcare System, Boston, MA, 6Duke University, Durham, NC, 7Washington DC VAMC/Georgetown and Howard Universities, Washington, DC, 8Dallas VA Medical Center, Dallas, TX, 9University of Pennsylvania, Philadelphia, PA, 10University of Utah and George E Wahlen VAMC, Salt Lake City, UT, 11VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA, 12Rocky Mountain Regional VAMC, Aurora, CO, 13Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA, 14University of Iowa, Iowa City, IA, 15VA Saint Louis and Washington University, Saint Louis, 16University of Nebraska Medical Center, Omaha, NE, 17University of Alabama at Birmingham (UAB), Birmingham VA Medical Center, Birmingham, AL, 18Salt Lake City VA/University of Utah, Salt Lake City, UT, 19VA Puget Sound Health Care System, Seattle, WA, 20Duke University Hospital, Durham, NC

    Background/Purpose: Clinical guidelines recommend the use of disease activity measures (DAMs) in rheumatoid arthritis (RA) management. Measurement of DAMs is also a critical component of…
  • Abstract Number: 2301 • ACR Convergence 2025

    Use of lived experiences in childhood Sjogren Disease to develop outcome measures for an N-of-1 treatment trial.

    Sara M. Stern1, Angela Merritt2, Ludovic Trinquart3, Emma Barnboym4, Michelle LeeBravatti3, Suzy Richins5, Tressie L. Rollins5, Hanna M. Salzman5, Marisha Palm3, Cortney M. Wieber6, Hermine Brunner7 and Nora G. Singer8, 1University of Utah, Salt Lake City, UT, 2Cincinnati Childrens Hospital Medical Center, Cincinnati, OH, 3Tufts University School of Medicine, Boston, MA, 4The MetroHealth System at Case Western Reserve University School of Medcine, Cleveland, OH, 5Pediatric Rheumatology, University of Utah, Salt Lake City, UT, 6Institute for Clinical Research and Health Policy Studies (ICRHPS) and CTSI, Tufts School of Medicine, Boston, MA, 7Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 8The MetroHealth System at Case Western Reserve University School of Medicine, Cleveland, OH

    Background/Purpose: Childhood Sjogren Disease (cSjD) is a rare disease that presents with a wide variety of symptoms. Compared to adult SjD, cSjD more frequently manifests…
  • Abstract Number: 2171 • ACR Convergence 2025

    Knowledge of Fertility and Infertility Treatments Among Physicians Treating Women with Rheumatic Diseases: FIT-KS Survey

    Andres M. Ortiz-Rios1, Mara Alejandra Ponce-Santillan1, Braulio R. Avalos-Garcia1, Eva Abigaid Galindo-Calvillo1, Carolina Treviño-Sanchez1, Samantha Lynn Salinas-Rodriguez1, Arantza Michelle Núñez-Elizondo2, Erendira Berenice Noyola-Sauceda1, Guadalupe Valentina Vazquez-Guerra1, Jesus Alberto Cardenas-de la Garza3, Lorena Perez-Barbosa1, Dionicio A. Galarza-Delgado4 and Cassandra Michele Skinner-Taylor1, 1Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico, 2Universidad Autónoma de Nuevo León, Rheumatology Service, Hospital Universitario "Dr. José Eleuterio González", Monterrey, Nuevo León, México., Monterrey, Nuevo Leon, Mexico, 3Rheumatology Service, University Hospital “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, México, Monterrey, Mexico, 4Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico

    Background/Purpose: Rheumatic diseases frequently affect individuals of reproductive age, and up to 40–70% may experience fertility issues related to disease activity, medications, delayed childbearing, and…
  • Abstract Number: 1990 • ACR Convergence 2025

    Pilot Study: Testing the Accuracy of a Capillary Point-of-Care Device Compared to Traditional Venous Analysis for Serum Urate Measurements Among Patients with Gout

    Alex Tinianow1, Saiajay Chigurupati1, Ethan Carey1, Jiaqi Wang2, Sharan Rai3, Gregory Challener4, Hyon K. Choi5, Philip Riches6, Natalie McCormick1 and Chio Yokose7, 1Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital, BOston, 3Massachusetts General Hospital/Harvard Medical School, Boston, MA, 4MGH, Boston, MA, 5MASSACHUSETTS GENERAL HOSPITAL, Lexington, MA, 6NHS Lothian, Edinburgh, UK, Edinburgh, United Kingdom, 7Massachusetts General Hospital, Waltham, MA

    Background/Purpose: Rheumatology guidelines endorse a treat-to-target (TTT) approach targeting serum urate (SU) < 6 mg/dL among patients with gout who qualify for urate-lowering therapy (ULT).…
  • Abstract Number: 1974 • ACR Convergence 2025

    Serial ferritin as a diagnostic surrogate marker in Hemophagocytic Lymphohistiocytosis (HLH), a retrospective single-center study

    Chen Chao1, Anna Lichtiger2, Xianhong Xie3, Melissa Fazzari4 and Ayesha Bibi5, 1Rheumatology Division, Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY, NY, 2Internal Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, The Bronx, NY, 3Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY, 4Department of Epidemiology & Population Health, Albert Einstein College of Medicine,, Bronx, NY, 5Rheumatology Division, Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Woodbridge Township, NJ

    Background/Purpose: Hemophagocytic lymphohistiocytosis (HLH) is an immune-mediated disorder characterized by cytokine dysregulation, resulting in multi-organ involvement and high mortality. (1-2) There is a time lag…
  • Abstract Number: 1970 • ACR Convergence 2025

    Comparison of Optical Imaging with Musculoskeletal Ultrasound in Assessment of PIP Joints of Systemic Lupus Erythematosus Patients

    Wei Tang1, Giovanna Rosas Chavez2, Leila Khalili2, Alberto Nordmann-Gomes3, Stephen Suh4, Alessandro Marone5, Moegammad Bardien5, Stephen Kim5, Laura Geraldino-Pardilla6, Andreas Hielscher5 and Anca Askanase2, 1Westchester Medical Center, Valhalla, NY, 2Columbia University Medical Center, New York, NY, 3Columbia University Irving Medical Center, New York, NY, 4Columbia University Irving Medical Center, New York City, NY, 5New York University Tandon School of Engineering, New York, NY, 6Columbia University, New York, NY

    Background/Purpose: Lupus arthritis has heterogeneous phenotypes and severity, complicating clinical management and trial endpoints. Advances in musculoskeletal ultrasound (MSK US) and optical imaging have been…
  • Abstract Number: 1635 • ACR Convergence 2025

    Association Between Treatment Adherence and Frailty in Patients with Rheumatic Diseases

    Daniela L. Guillen-Tejada1, Aura Matilde Jiménez-Garduño1 and Montserrat Lamuño Encorrada2, 1Universidad de las Américas Puebla, Puebla, Mexico, 2Hospital Ángeles Puebla, Puebla, Mexico

    Background/Purpose: Management of rheumatic diseases relies on chronic treatment, often with a greater risk of nonadherence. Frailty is characterized by decreased physiological function that increases patients’…
  • Abstract Number: 2558 • ACR Convergence 2024

    Development of Non-genetic Risk Stratification Model of Severe Allopurinol Hypersensitivity Syndrome, a Multicenter Study in Thailand

    Patapong Towiwat1, Wichittra Tassaneeyakul2, Suppachai Lawanaskol3, Chonlaphat Sukasem4, Nontaya Nakkam2, Ticha Rerkpattanapipat4, Jettanong Klaewsongkram5, Pawinee Rerknimitr5, Duangkamon Poolpun6, Worawit Louthrenoo7 and Niwat Saksit8, 1Naresuan university, Phitsanulok, Thailand, 2Khon Kaen university, Khon Kaen, Thailand, 3Chaiprakan hospital, Chiang Mai, Thailand, 4Mahidol university, Bangkok, Thailand, 5Chulalongkorn university, Bangkok, Thailand, 6Buddhachinaraj hospital, Phitsanulok, Thailand, 7Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand, Chiang Mai, Thailand, 8Phayao university, Phayao, Thailand

    Background/Purpose: Severe allopurinol hypersensitivity (SAH), although uncommon, is a serious adverse event of allopurinol.  Both genetic (HLA-B*58:01) and non-genetic factors (female gender, age ≥60-65 years,…
  • Abstract Number: 2605 • ACR Convergence 2024

    Clarifying Misbeliefs & Resolving Decisional Conflicts About Hydroxychloroquine (HCQ) Through a Shared Decision-Making Tool (HCQ-SAFE©)

    Shivani Garg1, Jay Patel1, Sancia Ferguson2, Betty Chewning3, Shelby Gomez4, Jon keevil5, David Gazeley6, Patricia Tellez-Giron1 and Christie Bartels7, 1University of Wisconsin, School of Medicine and Public Health, Madison, Madison, WI, 2University of Wisconsin, Madison, Madison, WI, 3University of Wisconsin, School of Pharmacy, Madison, 4UW Health, Madison, 5N/A, Madison, 6Medical College of Wisconsin, Wauwatosa, WI, 7University of Wisconsin School of Medicine and Public Health, Madison, WI

    Background/Purpose: Treatment of lupus (or SLE) is complex, especially for young patients who are committed to take hydroxychloroquine (HCQ) lifelong, which carries some risk, albeit…
  • Abstract Number: 2684 • ACR Convergence 2024

    Assessment of Skin in Patients with Systemic Sclerosis Using High Frequency Ultrasound : A Comparative Study with Histology and Clinical Parameters of Skin Disease

    Ruhani Desai1, Filemon Tan2, Minghua Wu3, Jefferey Browning4, Samuel Theodore3, Meng Zhang3, Brian Skaug3, Maureen Mayes3 and Shervin Assassi3, 1UTHealth Houston Division of Rheumatology, DeLand, FL, 2University of Texas at Houston McGovern Medical School, Houston, TX, 3UTHealth Houston Division of Rheumatology, Houston, TX, 4Boston Univeristy, Boston, MA

    Background/Purpose: The extent of skin involvement and its rate of progression can provide prognostic information for systemic sclerosis (SSc)-related morbidity and mortality. Moreover, skin assessment…
  • Abstract Number: 0358 • ACR Convergence 2024

    Residual’ Fatigue and Its Severity in Patients with Rheumatoid Arthritis in Clinical Remission: Prevalence and Associated Factors

    Rosa Maria Morlà Novell1, Beatriz Frade-Sosa2, Lola Tobalina Maestre3, Meritxell Sallés Lizarzaburu4, Virginia Ruiz-Esquide2, Maria López Lasanta5, Georgina Salvador Alarcón6, Noemí Busquets Pérez7, Marta Valls Roc8, Enrique Gonzalez Dávila9, Jose Alfredo Gomez-Puerta10 and Raimon Sanmartí Sala10, and ARCat study Group, 1Hospital Clínic de Barcelona, Barcelona, Spain, 2Hospital Clinic de Barcelona, Barcelona, Spain, 3Fundació Clinic per la Recerca clínica, Barcelona, Spain, 4Althaia Xarxa Assistencial Universitària Manresa, Manresa, Catalonia, Spain, 5Hospital Universitari Vall d´Hebron, Rheumatology, Barcelona, Spain, 6Hospital Mútua de Terrassa, Terrassa, Spain, 7HOSP. GENERAL DE GRANOLLERS, GRANOLLERS, Spain, 8Hospital Universitari Josep Trueta, Girona, 9Universidad de La Laguna, Santa Cruz de Tenerife, Spain, 10Rheumatology Department, Hospital Clinic of Barcelona, Barcelona, Spain

    Background/Purpose: Fatigue is a frequent and annoying symptom in rheumatoid arthritis (RA) patients that is often not assessed at routine follow-up visits. Residual’ fatigue has…
  • Abstract Number: 0387 • ACR Convergence 2024

    Absolute Agreement and Inter-rater Reliability of a Web-based Standardized Scoring Tool for Magnetic Resonance Images from Children with Chronic Nonbacterial Osteomyelitis (CNO) Amongst Radiologists

    Farzana Nuruzzaman1, T. Shawn Sato2, Jennifer Stimec3, Ramesh S. Iyer4, Andrew Carbert5, Joel Paschke5, Lauren Potts6, Xiaoyue Zhang7, Walter Maksymowych8, Polly Ferguson9 and Yongdong (Dan) Zhao10, and CARRA CRMO Workgroup, 1Stony Brook Children's Hospital, Stony Brook, NY, 2University of Iowa, Iowa City, 3Hospital for Sick Children, Toronto, ON, Canada, 4Seattle Children's Hospital, Seattle, WA, 5CARE Arthritis, Edmonton, AB, Canada, 6Artist, Long Beach, CA, 7Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 8University of Alberta, Edmonton, AB, Canada, 9University of Iowa Carver College of Medicine, Iowa City, IA, 10University of Washington, Redmond, WA

    Background/Purpose: The web-based ChRonic nonbacterial Osteomyelitis Magnetic Resonance Imaging Scoring (CROMRIS) portal was developed to assess specific features of bone and soft tissue inflammation in…
  • Abstract Number: 0456 • ACR Convergence 2024

    Use of Machine Learning to Evaluate Incremental Value of Actigraphy Data for Classifying Treatment Response in Patients with Rheumatoid Arthritis

    Jeffrey Curtis1, Yujie Su2, Cassie Clinton3, David Curtis4, Laura Stradford5, Patrick Zueger6, William Benjamin Nowell7, Pankaj Patel8, Esteban Rivera9, Kelly Gavigan4, Shilpa Venkatachalam10 and Fenglong Xie3, 1FASTER Medicine, Hoover, AL, 2Illumination Health, Hoover, AL, 3University of Alabama at Birmingham, Birmingham, AL, 4Global Healthy Living Foundation, Upper Nyack, NY, 5Global Healthy Living Foundation, Nyack, NY, 6AbbVie Inc, North Chicago, IL, 7Regeneron, New York, NY, 8AbbVie Inc., North Chicago, IL, 9Global Healthy Living Foundation, Long Island City, NY, 10Global Healthy Living Foundation, New York, NY

    Background/Purpose: Digital health technology to collect electronic patient reported outcomes (ePRO) and biosensor data are increasingly used to generate real-world data in pharmacoepidemiology. However, the…
  • Abstract Number: 0546 • ACR Convergence 2024

    Hiding in Plain Sight: The Impact of Implementing an Automated Inflammatory Back Pain Screening Tool on the Identification of Axial Spondyloarthritis in a Community Rheumatology Practice

    Nehad Soloman1, Jawad Bilal2 and John Tesser3, 1Arizona Arthritis & Rheumatology Associates, P.C., Glendale, AZ, 2Arizona Arthritis & Rheumatology Associates, PC, Tucson, AZ, 3Arizona Arthritis and Rheumatology Associates, P.C., Phoenix, AZ

    Background/Purpose: Axial spondyloarthritis (axSpA) is a chronic inflammatory disease affecting 1.4% of the US adult population.  The leading clinical symptom of axSpA is chronic inflammatory…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 7
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology